Sight Sciences, Inc. cash flow to debt ratio of -72.82% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Sight Sciences, Inc.'s free cash flow has decreased 31.59% from $-22.74M last year to $-29.92M, signaling decreasing performance

Sight Sciences, Inc.'s debt to equity ratio is 0.79, which means that the company's assets are unhealthy financed, signaling financial risk.

Sight Sciences, Inc.'s debt has increased relative to shareholder equity from 0.46 last year to 0.79 today, signaling weakened financials

Sight Sciences, Inc. has a net cash position, so leverage is healthy.

Sight Sciences, Inc.'s interest coverage ratio is -10.65, which means that the company struggles to meet interest obligations, signaling financial risk.

Sight Sciences, Inc.'s profit margin has increased (-44.66%) in the last year from -64.49% to -35.69%, signaling increasing performance

Sight Sciences, Inc.'s short-term assets of $112.73M exceed its short-term liabilities of $11.03M

Sight Sciences, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Sight Sciences, Inc.'s return on equity of -50.64%, is lower than 15.00%, indicating bad performance

Sight Sciences, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Sight Sciences, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Sight Sciences, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Sight Sciences, Inc. has negative free cash flow, indicating cash burn

Sight Sciences, Inc.'s yearly earnings has increased -25.40% since last year from $-51.51M to $-38.43M, signaling increasing performance

Sight Sciences, Inc.'s yearly revenue has decreased 3.13% since last year from $79.87M to $77.36M, signaling decreasing performance

ROIC -29.34% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Sight Sciences, Inc.'s 3-year revenue CAGR of 2.74% is positive, indicating growing revenue over the past 3 years

Sight Sciences, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Sight Sciences, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Sight Sciences, Inc. has insufficient data to evaluate this check.

Sight Sciences, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sight Sciences, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Sight Sciences, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Sight Sciences, Inc. has insufficient data to evaluate this check.

Sight Sciences, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sight Sciences, Inc. has a price-to-book ratio of 7.93x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Sight Sciences, Inc. has a price-to-sales ratio of 5.03x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue